Directors report REPORT OF THE DIRECTORS TO SHAREHOLDERS AND STAKEHOLDERS Financial The Directors submit their report together with the audited financial statements for the year Principal activity ended 31 December 2016.
This report forms The principal activities of the Group are the development, the management report for the purposes of manufacture and marketing of a broad range of generic, the Disclosure and Transparency Rules.
Readers branded and in-licensed pharmaceutical products in solid, are asked to cross refer to the other sections of semi-solid, liquid and injectable final dosage forms.
The the Annual Report to the extent necessary to Groups pharmaceutical operations are conducted through meet Hikmas reporting obligations as follows three business segments: Branded, Injectables and statements that are not applicable have Generics.
The majority of the Groups operations are been excluded : in the MENA region, the US and Europe.
The Group does not have overseas branches within the meaning Long-term incentive schemes: Directors of the Companies Act 2006 the Act.
remuneration report, pages 125 and 130 Related party transactions: Note 40 of The Groups net sales, gross profit and operating profit are the financial statements, page 193 shown by business segment in Note 4 to the consolidated financial statements on pages 163 to 165.
Going concern statement: Risk and control, page 61 Results Names and biographical details of the Directors: corporate governance report, pages 71 to 73 The Groups profit for the year in 2016 was $158 million 2015: $254 million.
Independence of Non-Executive Directors: corporate governance report, page 77 Dividend Directors share interests: Directors The Board is recommending a final dividend of 22 cents remuneration report, page 131 to 132 per share approximately 18 pence 2015: 21 cents.
Greenhouse gas emissions: Sustainability report, The proposed dividend will be paid on 25 May 2017 page 48 to shareholders on the register on 7 April 2017, subject Financial instruments and risk: Notes 30 and to approval at the Annual General Meeting AGM on 31of the financial statements page 182 to 187 19 May 2017.
An interim dividend of 11 cents per share was paid on 30 September 2016 2015: 11 cents.
The total dividend for the year 2016 is 33.0 cents per share 2015: 32.0 cents.
Creditor payment policy Hikmas policy, which is also applied by the Group and will continue in respect of the 2017 financial year, is to settle terms of payment with all suppliers when agreeing the terms of each transaction and to ensure that suppliers are made aware of and abide by the terms of payment.
Trade creditors of Hikma at 31 December 2016 were equivalent to 65 days purchases 2015: 81 days, based on the average daily amount invoiced by suppliers during the year.
